Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cognoa licenses Stanford's AI behavioral intervention technology for its ASD digital diagnostic device

Executive Summary

Cognoa exclusively licensed Stanford University School of Medicine's wearable artificial intelligence (AI)-powered behavioral intervention technology to accelerate development and worldwide commercialization of the company's own digital diagnostic and therapeutic device for children with autism spectrum disorder (ASD), a developmental disability that can cause significant social, communication, and behavioral challenges.
Deal Industry
  • Digital Health
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
    • Rehabilitation Equipment and Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies